Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cureus|September 22, 2025
Long-Term Proton Pump Inhibitor Use and the Risk of Kidney Disease, Dementia, and Fractures: A Systematic ReviewMahrukh Chaudhry, Mussavir Elahi, Syed Hassan Ali Bukhari, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Leukemia & Lymphoma|January 20, 2022
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphomaDong Won Kim, Ali Bukhari, Forat Lutfi, et al.
European Journal of Haematology|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T RecipientsChiranjeevi Sainatham, Olga Goloubeva, Philip Margiotta, et al.
Neuro-Oncology|August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomesNoa G Holtzman, Hao Xie, Soren Bentzen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional TrialMatthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T TherapyForat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Transplantation Proceedings|January 12, 2023
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center ExperienceHanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, et al.
Pageof 5